Clinical Trial Update: Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether intensifying HIV therapy with maraviroc improves viral latency outcomes in recently infected, ART-naïve patients starting ralte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)
• Raltegravir (raltegravir)
• Tenofovir/emtricitabine (tenofovir/emtricitabine)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 3 | Status: COMPLETED